| Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study M Tunca, H Ozdogan, O Kasapcopur, F Yalcinkaya, E Tutar, R Topaloglu, ... Medicine (Baltimore) 84 (1), 1-11, 2005 | 1002 | 2005 |
| EULAR recommendations for the management of familial Mediterranean fever S Ozen, E Demirkaya, B Erer, A Livneh, E Ben-Chetrit, G Giancane, ... Annals of the rheumatic diseases 75 (4), 644-651, 2016 | 542 | 2016 |
| A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard … N Ruperto, KJ Murray, V Gerloni, N Wulffraat, SK Feitosa De Oliveira, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2004 | 470 | 2004 |
| Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statement T Kallinich, D Haffner, T Niehues, K Huss, E Lainka, U Neudorf, ... Pediatrics 119 (2), e474-e483, 2007 | 331 | 2007 |
| Vasculitis in familial Mediterranean fever. H Ozdogan, N Arisoy, O Kasapcapur, L Sever, S Calişkan, N Tuzuner, ... The Journal of rheumatology 24 (2), 323-327, 1997 | 327 | 1997 |
| Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever I Touitou, T Sarkisian, M Medlej‐Hashim, M Tunca, A Livneh, D Cattan, ... Arthritis & Rheumatism 56 (5), 1706-1712, 2007 | 322 | 2007 |
| Recommendations for the management of autoinflammatory diseases NM Ter Haar, M Oswald, J Jeyaratnam, J Anton, KS Barron, PA Brogan, ... Annals of the rheumatic diseases 74 (9), 1636-1644, 2015 | 300 | 2015 |
| Evidence-based provisional clinical classification criteria for autoinflammatory periodic fevers S Federici, MP Sormani, S Ozen, HJ Lachmann, G Amaryan, P Woo, ... Annals of the rheumatic diseases 74 (5), 799-805, 2015 | 287 | 2015 |
| Evidence-based recommendations for genetic diagnosis of familial Mediterranean fever G Giancane, NM Ter Haar, N Wulffraat, SJ Vastert, K Barron, V Hentgen, ... Annals of the rheumatic diseases 74 (4), 635-641, 2015 | 218 | 2015 |
| Familial aggregation in Behçet’s disease: high frequency in siblings and parents of pediatric probands I Koné-Paut, I Geisler, B Wechsler, S Ozen, H Ozdogan, M Rozenbaum, ... The Journal of pediatrics 135 (1), 89-93, 1999 | 214 | 1999 |
| Familial mediterranean fever H Ozdogan, S Ugurlu La Presse Médicale 48 (1), e61-e76, 2019 | 180 | 2019 |
| Proxy‐reported health‐related quality of life of patients with juvenile idiopathic arthritis: the Pediatric Rheumatology International Trials Organization multinational quality … S Oliveira, A Ravelli, A Pistorio, E Castell, C Malattia, AM Prieur, ... Arthritis Care & Research: Official Journal of the American College of …, 2007 | 171 | 2007 |
| The Turkish version of the childhood health assessment questionnaire (CHAQ) and the child health questionnaire (CHQ) H Ozdogan, N Ruperto, O Kasapçopur, A Bakkaloglu, N Arisoy, S Ozen, ... Clinical and experimental rheumatology 19 (4; SUPP/23), S158-S162, 2001 | 159 | 2001 |
| Fever of unknown origin: a review of 20 patients with adult-onset Still's disease A Mert, R Ozaras, F Tabak, M Bilir, R Ozturk, H Ozdogan, Y Aktuglu Clinical rheumatology 22, 89-93, 2003 | 143 | 2003 |
| Treatment options in colchicine resistant familial Mediterranean fever patients: thalidomide and etanercept as adjunctive agents. E Seyahi, H Ozdogan, S Celik, S Ugurlu, H Yazici Clinical and experimental rheumatology 24 (5 Suppl 42), S99-103, 2006 | 140 | 2006 |
| Serum soluble intercellular adhesion molecule 1 and interleukin 8 levels in familial Mediterranean fever. H Direskeneli, H Ozdogan, C Korkmaz, T Akoglu, H Yazici The Journal of rheumatology 26 (9), 1983-1986, 1999 | 137 | 1999 |
| Results from a multicentre international registry of familial Mediterranean fever: impact of environment on the expression of a monogenic disease in children S Ozen, E Demirkaya, G Amaryan, I Koné-Paut, A Polat, P Woo, Y Uziel, ... Annals of the Rheumatic Diseases 73 (4), 662-667, 2014 | 130 | 2014 |
| International multi-centre study of pregnancy outcomes with interleukin-1 inhibitors T Youngstein, P Hoffmann, A Gül, T Lane, R Williams, DM Rowczenio, ... Rheumatology 56 (12), 2102-2108, 2017 | 113 | 2017 |
| Efficacy and safety of canakinumab in adolescents and adults with colchicine-resistant familial Mediterranean fever A Gül, H Ozdogan, B Erer, S Ugurlu, O Kasapcopur, N Davis, S Sevgi Arthritis research & therapy 17, 1-5, 2015 | 109 | 2015 |
| Rate and clinical presentation of macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis treated with canakinumab AA Grom, NT Ilowite, V Pascual, HI Brunner, A Martini, D Lovell, ... Arthritis & Rheumatology 68 (1), 218-228, 2016 | 106 | 2016 |
